The Association for Accessible Medicines and its Biosimilars Council advocates in state and federal courts to support patient access to affordable generic and biosimilar medicines. We file amicus briefs in litigation that affects the ability of our members to deliver such medicines to patients in need. Below you will find recent amicus briefs that AAM has filed on behalf of our member companies.
Register Now - Next Steps Workshop to explore the science, manufacturing & quality components of generics + biosimilars.
